A non-cytotoxic regimen of decitabine to treat refractory T-cell
large granular lymphocytic leukemia
Misam Zawit1*, Carmelo Gurnari1,2*,
Simona Pagliuca1,3 , Hassan Awada1,
Jaroslaw P. Maciejewski1 and Yogen
Saunthararajah1
*These authors contributed equally